Market Overview

Benzinga's Top #PreMarket Gainers

Related QURE
Benzinga's Top Upgrades, Downgrades For December 31, 2018
64 Biggest Movers From Yesterday
FDA clears UniQure's IND for AMT-130 (Seeking Alpha)
Related MNOV
The Daily Biotech Pulse: BioMarin Trims Outlook, MediciNova Enrolls First Patient In Brian Cancer Drug Study
The Daily Biotech Pulse: MediciNova Gets Orphan-Drug Status, KemPharm To Offer Shares, Emergent Buys Vaccine Maker
MediciNova nabs new patent for MN-166 and riluzole combination; shares up 5% premarket (Seeking Alpha)

Uniqure NV (NASDAQ: QURE) shares rose 12.01 percent to $16.70 in pre-market trading after the company reported preliminary topline results from low-dose cohort in Hemophilia B Phase I/II gene therapy clinical trial.

Zumiez Inc. (NASDAQ: ZUMZ) shares rose 6.23 percent to $16.02 in pre-market trading after the company raised its guidance for the fourth quarter. The company's comparable sales slipped 8.9 percent for December.

MediciNova, Inc. (NASDAQ: MNOV) shares rose 5.82 percent to $4.00 in pre-market trading after dropping 0.53 percent on Wednesday.

EZchip Semiconductor Ltd (NASDAQ: EZCH) shares rose 2.85 percent to $25.25 in pre-market trading. EZchip Semiconductor's largest shareholder, Raging Capital Management, LLC, announced its support for EZchip/Mellanox merger.

Constellation Brands, Inc. (NYSE: STZ) shares rose 1.31 percent to $145.00. Constellation Brands reported Q3 earnings of $1.42 per share on sales of $1.641 billion. The company also lifted its 2016 guidance.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers


Related Articles (EZCH + MNOV)

View Comments and Join the Discussion!

Different Ways To Turn The Lights On With Utilities ETFs

Barclays Sees Headwinds At Chipotle 'Large,' Cuts Target To $465